Sales Director

• Jun 2020 - Present

Regional Sales Director

• Jul 2016 - Jun 2020

15 Territory Business Manager direct reports in Respiratory Medicine for 4 states, NYC, NJ, CT, Boston. • Recruited and helped build two expansion teams over 3 years totaling 200 Reps. • Developed and promoted 1 representative to Regional Sales Manager. • 2019: #1 Growth region, nationally. Exceeded national average by 4%. • 2019: #1 in company for combined revenue; COPD ($2,201,700) and NIOX ($797,029) 2019. • 2019: Increased new prescribers by 20% for Tudorza. • 2018 President’s Club winner. • 2018: 106% to region quota NIOX device sales. • 2018: Grew market share with ESI, United HealthCare, Emblem and Local 1199 & Medicare Part D by 3%. • 2017 & 2018: Recognized for and Ranked #1 out of 18 Regions in the nation for combined sales. • 2017: Produced 25% of nations’ new devices (27% of TK volume) and 30% of nation’s repeat TK volume. • Developed economic model for dollarized value of FeNO for HCPs & group practices. • Produced 5 President’s Club winners over past three years 2016-2019. Show less

National Sales Director

• Jul 2012 - Jun 2016

National Sales Manager, Perrigo Project, November 2015 – June 2016 • Built National Sales Team of 100 Reps to “re-launch” three women’s health products targeting OB/GYN & Primary Care HCPs. Account Director/Director of Business Development at Pfizer, NYC, August 2014 – November 2015 Lead for OnCall’s U.S. Contract Sales Team at Pfizer & other RFPs • Landed numerous RFPs on Pfizer Pilots which turned 4 Pilots into long term projects: Pfizer’s Women’s Health Division, Primary Care, Vaccines, Specialty Care and DTC Divisions. • Exceeded TRx sales goals with Premarin Oral/Vaginal Cream. • Expanded Pfizer’s Women’s Health Sales team and launch of Duavee. Show less

Sales for Health Care Division

• Jun 2010 - Jun 2012

• Landed Dermatology Pharmaceuticals account to build a selling model, increased sales by 7 %. • Landed Human Genome Sciences account. Produced pre-call planning workshop for BENLYSTA lupus drug. • Landed Vertex Pharma account. Built internal company audit. Saved $100K in lost revenue. • Landed Janssen account for SFE with Invega Sustenna (schizophrenia patients/Psychiatrists targets). • Landed Nutricia account for management, leadership & coaching program. • 5% ROI on designed coaching workshop for Novartis DSMs for Diovan, Tekturna, and Valturna. Show less

Regional Sales Manager

• Jan 2007 - Dec 2009

Responsible for N.J. cardiovascular/metabolic portfolio, selling to HCPs, Hospitals & Institutions.• Sales Achievement Award 2008: Ranked top Region East area; top 15% in the nation of 183 Regions• Special Achievement Award 2008: “All-in” campaign to motivate & inspire teams to win against Lipitor.• First Team in Northeast and Mid-Atlantic Regions to reach 20% market share with Crestor.• Consistently delivered sales results exceeding expectations #1 or #2 region in nation (top 10% or better).• Co-authored Interactive Strategic Selling model & account based selling strategy in N.J. region.• Uncovered opportunity to increase share with key Managed Care plans with an innovative campaign on reimbursement issues targeting top accounts affiliated with Caremark, Horizon BCBS and Medicare Part D.• Developed a N.J. Field Input team to reach retail pharmacists for Onglyza launch.• Launched new indication for statin Crestor and launched diabetes product Onglyza.• Developed and promoted 2 Reps to District Manager, 2 Reps to Trainer position, 1 Rep to Marketing. Show less

Sales & Marketing Liason, Respiratory

• Apr 2006 - Jan 2007

• Organized launch strategy for “Symbicort” and “Pulmicort Respules .5mg” products.• Leadership award for Symbicort COPD launch.• Revamped AZ launch strategy and shortened original Symbicort launch timeline by 3 months.• Developed Sales Training Program for Symbicort launch. Crestor and Nexium brands used for next National Sales Meeting.

Director of Operations

• Jul 2003 - Apr 2006

Oversaw 5 Therapeutic Areas: North Carolina to Pennsylvania.• Special Achievement Award 2004 for exceptional sales results (top 10%).• Increased retention rates by 10% in 2005.• Managed operational headcount reduction by 20%; and sales management by 12%.• Received 1 of 6 National Awards in 2005 for creating & delivering Diversity Training program.• PGA Charity Events built to give back to the local healthcare communities based on the Tour Professionals healthcare charity of choice. Show less

Regional Sales Director

• Aug 1999 - Jun 2003

Managed Cardiovascular and Gastrointestinal Regional franchise of 88 direct reports, 8 District Managers, 3 Regional Trainers, and 12 Contract Reps generating $1.2 MUSD in sales. • 2003 President’s Club winner.• Ranked 2nd with launch of Nexium 2001. Ranked #1 in Nation with product Prilosec in 2000.• Developed “Operation Tea Party” marketing campaign that increased Nexium market Share by 10% within 9 months.• Designed “regionalization” strategy of resource allocation based on sales potential and trends.• Created and implemented a system to interview and hire 300 Sales Reps within six months.• Developed and promoted 4 Reps to District Manager, 2 Reps to Trainer and 2 Reps into Analytics. Show less

Regional Sales Manager

• Sep 1998 - Aug 1999

Integrated Cardiovascular and Gastrointestinal teams comprised of 3 managers and 27 reps during merger. • 100% employee retention during merger with Zeneca Pharmaceuticals in 1999.• Ranked #1 with 3 of 6 products in 1999. Over 100% to plan on all 6 products in 1999.• Sales increased 15% from $360,000 to $415,000 in 5 months.

Product Manager

• Jun 1997 - Sep 1998

Lead role for Executive Committee and key US operating team to determine product lifecycle strategies across the entire product portfolio. Business Development: Identifying and evaluating new asset acquisitions and divestitures. Managed licensee relations.• Increased annual sales 25% in one year to have 1st 100 million dollar product in 1997.• Grew revenue from $141 Million grew to $177 Million in 1998.• Created the first ever U.S. Beta-Blocker Council; 50 National thought leaders in CV medicine.• Expanded Heart Failure indication which later grew Toprol-XL to over 1 Billion dollars. Show less

District Sales Manager

• May 1994 - Jun 1997

• Inherited District dead last in 1994, grew it to 2nd in 1995, President’s Club winner in 1996, and ranked 2nd in 1997.

Representative

• Oct 1991 - May 1994

Sales Representative, Cardiovascular Products, Westchester Co., NY (1991-1994) •Finished in the top 10% nationally three straight years. Sales Representative, Cardiovascular Products, Westchester Co., NY (1991-1994) •Finished in the top 10% nationally three straight years.